Commentary

A Generation of Progress in Endocrinology, Especially Cardiovascular Endocrinology

Author and Disclosure Information

So much has happened in the field of endocrinology over the past 30 years that it is truly a challenge to know where to begin. Since I fancy myself a cardiovascular endocrinologist who uses endocrine principles to reduce cardiovascular disease, I’ll focus primarily on 3 related areas: diabetes, dyslipidemia, and hypertension.


 

Recommended Reading

Glucose Excursions Linked to Ventricular Tachycardia
Type 2 Diabetes ICYMI
Weight Gain Following Diabetes Diagnosis Boosts Mortality
Type 2 Diabetes ICYMI
FREEDOM: CABG Shows Excellent Cost Effectiveness
Type 2 Diabetes ICYMI
Practice Changer: CABG Bests Multivessel Stenting in Diabetes
Type 2 Diabetes ICYMI
Insulin Degludec's Long Duration Sways FDA Panel
Type 2 Diabetes ICYMI
Statins Sever the Diabetes and Coronary Disease Link
Type 2 Diabetes ICYMI
In Type 1 Diabetes, Cardiac Measures Improved After Pancreas Transplant
Type 2 Diabetes ICYMI
DPP-4 Inhibitors for Diabetes May Cut Cardiovascular Risk
Type 2 Diabetes ICYMI
Statins' Diabetogenic Impact Influenced by Underlying Risks
Type 2 Diabetes ICYMI
Statins and diabetes risk: Fact, fiction, and clinical implications
Type 2 Diabetes ICYMI